Financials
- Market Capitalization 2.12 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
112.53
ratio cours/chiffre d'affaires
6.8
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1940 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.68 USD | -4.00% | -7.34% | +6.28% | +129.89% | 2.14 B USD | ||
| 1949 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.42 USD | -0.36% | -2.09% | +9.83% | +37.64% | 2.18 B USD | ||
| 1973 | NBTX Nanobiotix S.A. - ADSs | 41.01 USD | -9.19% | -5.96% | +9.30% | +340.97% | 1.99 B USD | ||
| 1975 | ADMA ADMA Biologics Inc - Common Stock | 9.43 USD | -0.53% | -3.18% | +8.27% | -45.80% | 2.11 B USD |